Neogen Corporation (NEOG) Income Statement

NASDAQ: NEOGRevenue, profits, margins and EPS over 10 years.

NEOG FY2026 at a glance

Fiscal year ended May 31, 2026 · U.S. dollars
Revenue−2.7%
$870.4M
FY2026 · hover or tap a bar for each year
FY2017: $361.6M (+12.5%)FY2018: $402.3M (+11.2%)FY2019: $414.2M (+3.0%)FY2020: $418.2M (+1.0%)FY2021: $468.5M (+12.0%)FY2022: $527.2M (+12.5%)FY2023: $822.4M (+56.0%)FY2024: $924.2M (+12.4%)FY2025: $894.7M (−3.2%)FY2026: $870.4M (−2.7%)
FY2017FY2026
Gross profit−3.1%
$408.5M
FY2026 · hover or tap a bar for each year
FY2017: $172.0M (+12.4%)FY2018: $190.3M (+10.6%)FY2019: $191.9M (+0.9%)FY2020: $196.3M (+2.3%)FY2021: $215.1M (+9.6%)FY2022: $243.0M (+13.0%)FY2023: $406.0M (+67.1%)FY2024: $462.6M (+14.0%)FY2025: $421.4M (−8.9%)FY2026: $408.5M (−3.1%)
FY2017FY2026
Operating income−329.3%
−$21.6M
FY2026 · hover or tap a bar for each year
FY2017: $64.9M (+15.2%)FY2018: $70.2M (+8.1%)FY2019: $68.1M (−3.0%)FY2020: $67.5M (−0.8%)FY2021: $74.2M (+9.8%)FY2022: $58.6M (−21.0%)FY2023: $37.5M (−36.0%)FY2024: $77.4M (+106.4%)FY2025: $9.4M (−87.8%)FY2026: −$21.6M (−329.3%)
FY2017FY2026
Net income
−$7.9M
FY2026 · hover or tap a bar for each year
FY2017: $43.8M (+19.8%)FY2018: $63.1M (+44.2%)FY2019: $60.2M (−4.7%)FY2020: $59.5M (−1.2%)FY2021: $60.9M (+2.4%)FY2022: $48.3M (−20.7%)FY2023: −$22.9M (−147.3%)FY2024: −$9.4MFY2025: −$1.09BFY2026: −$7.9M
FY2017FY2026
EPS (diluted)−6.1%
$0.31
FY2026 · hover or tap a bar for each year
FY2017: $0.43 (+19.4%)FY2018: $0.55 (+27.9%)FY2019: $0.58 (+5.5%)FY2020: $0.58 (0.0%)FY2021: $0.58 (0.0%)FY2022: $0.53 (−8.6%)FY2023: $0.56 (+5.7%)FY2024: $0.44 (−21.4%)FY2025: $0.33 (−25.0%)FY2026: $0.31 (−6.1%)
FY2017FY2026
Net profit margin+121.2 pts
−0.9%
FY2026 · hover or tap a point for each year
FY2017: 12.1% (+0.7 pts)FY2018: 15.7% (+3.6 pts)FY2019: 14.5% (−1.2 pts)FY2020: 14.2% (−0.3 pts)FY2021: 13.0% (−1.2 pts)FY2022: 9.2% (−3.8 pts)FY2023: −2.8% (−11.9 pts)FY2024: −1.0% (+1.8 pts)FY2025: −122.1% (−121.0 pts)FY2026: −0.9% (+121.2 pts)
FY2017FY2026

NEOG revenue and net income

RevenueNet incomeNet margin (right axis)

Where NEOG's revenue goes

FY2026
Revenue
$870.4M100.0%
Cost of revenue
−$461.9M−53.1%
Gross profit
$408.5M46.9%
Research & development
−$18.4M−2.1%
Sales, general & admin
−$411.7M−47.3%
Operating income
−$21.6M−2.5%
Interest & other income
$12.6M1.4%
Net income
−$7.9M−0.9%

Each bar shows an amount and its share of revenue. NEOG kept −0.9% of revenue as net income.

NEOG profit margins

GrossOperatingNet

NEOG growth rates

to FY2026
1 year3 years5 years10 years
Revenue−2.7%+1.9%+13.2%+10.5%
Gross profit−3.1%+0.2%+13.7%+10.3%
Operating income−329.3%———
Net income————
EPS (diluted)−6.1%−17.9%−11.8%−1.5%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

NEOG quarterly EPS vs estimates

Reported EPSAnalyst estimate

Neogen beat the analyst EPS estimate in 7 of the last 8 quarters.

NEOG income statement

Neogen Corporation annual income statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$870.4M$894.7M$924.2M$822.4M$527.2M$468.5M$418.2M$414.2M$402.3M$361.6M
Cost of revenue$461.9M$473.3M$461.6M$416.5M$284.1M$253.4M$221.9M$222.3M$212.0M$189.6M
Gross profit$408.5M$421.4M$462.6M$406.0M$243.0M$215.1M$196.3M$191.9M$190.3M$172.0M
Research & development$18.4M$21.1M$22.5M$26.0M$17.0M$16.2M$14.8M$12.8M$10.9M$10.4M
Sales, general & admin$411.7M$218.2M$199.9M$342.4M$167.3M$124.6M$114.0M$111.0M$109.2M$96.6M
Total operating expenses$430.1M$412.0M$385.2M$368.4M$184.4M$140.9M$128.8M$123.8M$120.1M$107.0M
Operating income−$21.6M$9.4M$77.4M$37.5M$58.6M$74.2M$67.5M$68.1M$70.2M$64.9M
Interest income—$3.1M$6.4M$3.2M$1.3M$1.6M$6.0M$4.7M$2.0M$838,000
Interest expense$57.6M$71.6M$73.4M$56.0M$72,000$78,000$23.2M$22.5M$0$0
Income before taxes−$9.0M−$1.13B−$14.3M−$22.0M$60.2M$75.3M$72.3M$73.0M$73.5M$66.7M
Income taxes−$1.1M−$41.1M−$4.9M$828,000$11.9M$14.4M$12.8M$12.8M$10.2M$22.7M
Net income−$7.9M−$1.09B−$9.4M−$22.9M$48.3M$60.9M$59.5M$60.2M$63.1M$43.8M
EBITDA$164.9M−$937.8M$182.6M$125.9M$84.3M$96.3M$90.7M$90.6M$87.3M$79.6M
EPS (diluted)$0.31$0.33$0.44$0.56$0.53$0.58$0.58$0.58$0.55$0.43
Gross margin46.9%47.1%50.1%49.4%46.1%45.9%46.9%46.3%47.3%47.6%
Operating margin−2.5%1.1%8.4%4.6%11.1%15.8%16.1%16.4%17.5%18.0%
Net margin−0.9%−122.1%−1.0%−2.8%9.2%13.0%14.2%14.5%15.7%12.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NEOG's financial statements (latest annual report filed July 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

NEOG financial results

In fiscal year 2026 (ended May 31, 2026), Neogen reported revenue of $870.4 million, down 2.7% from the year before. It had a net loss of $7.9 million, a net profit margin of −0.9%. Diluted earnings per share came to $0.31. Over five years revenue grew at an average rate of 13.2% a year.

See the NEOG stock overview for the latest quote and news, or the NEOG chart for price history and technical indicators.

NEOG income statement FAQ

What is Neogen's annual revenue?

Neogen reported total revenue of $870.4 million for fiscal year 2026, which ended on May 31, 2026. That was down 2.7% from $894.7 million the previous year.

Is Neogen profitable?

No. Neogen reported a net loss of $7.9 million in fiscal 2026, a net profit margin of −0.9%; its operating margin was −2.5%.

What is Neogen's gross margin?

Neogen's gross margin was 46.9% in fiscal 2026: for every $100 of revenue, Neogen kept $47 after the direct cost of its products and services.

How much does Neogen spend on research and development?

Neogen spent $18.4 million on research and development in fiscal 2026, 2.1% of revenue.

How fast is Neogen growing?

Revenue grew 13.2% a year on average over the last five fiscal years, from $468.5 million to $870.4 million.

What are Neogen's earnings per share?

Neogen earned $0.31 per diluted share in fiscal 2026, compared with $0.33 a year earlier.

When does Neogen's fiscal year end?

Neogen's fiscal year ends in May. The latest annual report covers the year ended May 31, 2026 and was filed on July 30, 2026.

Medical Devices income statements